Corneal melt in rheumatic disorders: Effect of disease-modifying antirheumatic drugs on morbidity

Journal of Clinical Rheumatology

Volumn 11, Issue 3, 2005, Pages 134-139

  Saripalli, Leela ^a,b   Harrington, Thomas M ^a   Notz, Robert G ^a   Torretti, Dennis ^a  

^a GEISINGER MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Corneal melt; Corneal ulcer; Relapsing polychondritis; Rheumatoid arthritis; Sj gren syndrome

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; AZATHIOPRINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYANOACRYLATE; DAPSONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FIBRONECTIN; GOLD; HISTAMINE H1 RECEPTOR ANTAGONIST; LEFLUNOMIDE; LUBRICATING AGENT; METHOTREXATE; MUCOLYTIC AGENT; MYDRIATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; RHEUMATOID FACTOR; STEROID; VITAMIN;

ADULT; AGED; ARTICLE; ASTIGMATISM; BANDAGE; CLINICAL ARTICLE; CONTACT LENS; CONTROLLED STUDY; CORNEA SURGERY; CORNEA TRANSPLANTATION; CORNEA ULCER; CORNEAL MELT; DACRYOCYSTITIS; DISEASE ASSOCIATION; ENDOPHTHALMITIS; EYE DISEASE; EYE INFLAMMATION; FEMALE; HUMAN; KERATOPLASTY; LUNG TUBERCULOSIS; MALE; MORBIDITY; PENETRATING KERATOPLASTY; PERFORATION; PRIORITY JOURNAL; RELAPSING POLYCHONDRITIS; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCLEROMALACIA; SJOEGREN SYNDROME; SUPERINFECTION; SYMPTOMATOLOGY; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CORNEAL DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYCHONDRITIS, RELAPSING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 20844436927     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000164819.23298.53     Document Type: Article

References (16)

1. Shiuey Y, Foster CS. Peripheral ulcerative keratitis and collagen vascular disease. Int Ophthalmol Clin. 1998;38:21-32.
2. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Ophthalmology. 1984;91:1253-1263.
3. Squirrel DM, Winfield J, Amos RS. Peripheral ulcerative keratitis 'corneal melt' and rheumatoid arthritis: a case series. Rheumatology. 1999;38:1245-1248.
4. Messemer EM, Foster CS. Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea. 1995;14:408-417.
5. Riley GP, Harral RL, Watson PG, et al. Collagenases (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye. 1995;9:703-718.
6. Messemer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol. 1999;43.
7. Foster CS. Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology. 1980;87.
8. Ladas JG, Mondino BJ. Systemic disorders associated with peripheral corneal ulceration. Curr Opin Ophthalmol. 2000;11:468-471. Deleted in proof.
9. Jifi-Bahlool H, Saadeh C, O'Connor J. Peripheral ulcerative keratitis in the setting of rheumatoid arthritis: treatment with immunosuppressive therapy, Semin Arthritis Rheum. 1995;25:67-73.
10. McCarthy JM, et al. Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis. J Rheumatol. 1992;19:1358-1361.
11. Wilson DM, et al. Peripheral ulcerative keratitis-an extracutaneous neutrophilic disorder: report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy. J Am Acad Dermatol. 1999;40:331-334.
12. Kervick GN, et al. Paracentral rheumatoid corneal ulceration. Ophthalmology. 1992;99:80-88.
13. Vivino FB, et al. Corneal Melt as the initial presentation of primary Sjögren's syndrome. J Rheumatol. 2001;28:379-382.
14. Sule A, et al. Rheumatology. 2002;41:705-706.
15. Hernandez-Illas M, et al. Recombinant human tumor necrosis factor receptor Fc fusion protein (etanercept): experience as a therapy for sight threatening scleritis and sterile corneal ulceration. Eye Contact Lens. 2004;30:2-5.
16. Tauber J, Sainz de la Maza M, Hoang-Xuan T, et al. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990;9:66-73.